Cook Steven L. sold $292K of OMDA

Cook Steven L. (Chief Financial Officer) sold 12,150 shares of Omada Health, Inc. (OMDA) at an average of $24.01 ($24.00–$24.01, $0.29M total) across 2 trades on 2026-07-15 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Cook Steven L.
Published Jul 17, 2026, 8:39 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jul 17, 2026, 8:41 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$OMDA
Neutral
medium confidence
Mentioned
$OMDA
Relevance
3/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$OMDANeutralLow
01

Why it matters

The disclosed sale is unlikely to change the company’s fundamentals, but it provides a fresh datapoint on insider activity.

02

Market read

Traders may monitor insider activity for sentiment, but this specific filing lacks new company-specific fundamentals.

03

What to watch

Check whether there is a pattern of repeated insider sales across multiple filings, and whether any other contemporaneous disclosures (earnings, guidance, financing) exist.

Relevance 3/10Novelty 3/10Timing: new Form 4 filed after-hours (filed 2026-07-17)

Background

The article is an SEC Form 4 insider transaction disclosure for Omada Health, Inc.

Company-level read

Ticker impact

$OMDANeutralMedium confidence
Context

Omada Health CFO Steven L. Cook sold 12,150 shares in open-market transactions at about $24.01 per share under a 10b5-1 plan.

Expected impact

Likely limited, short-lived impact unless follow-on insider selling accelerates or coincides with other negative news.

Evidence & confidence

The filing is a Form 4 insider transaction with a pre-arranged 10b5-1 plan; the article provides no new operational, financial, or regulatory developments.

Market effects

No clear sector read-through from a single CFO 10b5-1 sale.

None indicated.

None indicated.

Counterpoint

A 10b5-1 sale is often mechanical and may not reflect bearish expectations; the CFO may be diversifying or funding personal liquidity needs.

Key entities

  • Omada Health, Inc.

    Subject of the Form 4 insider transaction disclosure.

  • Steven L. Cook

    Chief Financial Officer who sold shares under a pre-arranged 10b5-1 plan.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$OMDAHigh

Omada Health Earnings Call Signals Strong Growth Ahead

Omada Health (OMDA) reported Q3 revenue of $91M, up 34% YoY, with GAAP net income of $7M vs. a loss last year. Adjusted EBITDA rose to $12M. Management raised 2026 revenue guidance to $344M-$346M and adjusted EBITDA to $32M-$34M, citing strong demand for diabetes and hypertension programs. The company expects Q4 seasonality and GLP-1 coverage uncertainty.

$OMDAMed

What Omada Health (OMDA) Said on Its Q3 Earnings Call

Omada Health (OMDA) expects Q4 revenue to decline due to seasonal factors, with adjusted EBITDA also moderating. The company ended Q3 with $243M in cash and no debt. CEO Sean Duffy will transition to executive chair in 2027, with Shao taking over as CEO. Omada's GLP-1 Care Track showed a 6% average weight loss at 12 weeks, according to peer-reviewed research.

$OMDAMedAI 8/10

Omada Health Inc (OMDA) (Q3 2026) Earnings Call Highlights: Record Revenue, Membership

Omada Health Inc (OMDA) reported record revenue and membership growth in Q3 2026. However, new enrollments are expected to decline in Q4 due to seasonality and tough comparisons. GLP-1 market dynamics and rising healthcare costs create uncertainty for 2027. Adjusted EBITDA is expected to moderate due to increased R&D and staffing. The company aims for 20%+ growth in 2027 through expanding covered lives, improving enrollment rates, and increasing engagement.